Status:
UNKNOWN
Testing Spectrosense EVA System for Detection of Breast Cancer by Analyzing Volatile Organic Compounds (VOCs) in Exhaled Air
Lead Sponsor:
Rauscher, Gregory E., M.D. PA
Conditions:
Breast Cancer
Eligibility:
FEMALE
18+ years
Brief Summary
Volatile Organic Compounds (VOC) in human breath are captured and analyzed by the Spectrosense EVA system, which is combination of a gas chromatography (GC) and software algorithm. The objective is to...
Eligibility Criteria
Inclusion
- Breast Cancer group:
- Age from 18 years old
- Breast cancer positive biopsy
- Before any treatment
- Signed Informed Patient Consent
Exclusion
- Age under 18 years old
- Neoadjovant treatment
- Post surgery for breast cancer
- A history of any other cancer type, except skin cancer that is not melanoma
- Healthy group:
- Inclusion Criteria:
- Healthy women
- No history of Breast cancer
- Signed Informed Patient Consent
Key Trial Info
Start Date :
May 1 2013
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
Estimated Enrollment :
600 Patients enrolled
Trial Details
Trial ID
NCT01849328
Start Date
May 1 2013
Last Update
November 19 2013
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Englewood Hospital and Medical Center
Englewood, New Jersey, United States, 07631